MedPath

Prosperity of celecoxib for pain relief after elective cesarean section delivery, a double-blind randomized controlled trial

Phase 3
Conditions
/A
Registration Number
TCTR20190109003
Lead Sponsor
/A
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending (Not yet recruiting)
Sex
Female
Target Recruitment
100
Inclusion Criteria

-term prgnancy
-singleton
-age 20 †40 year-old
-elective cesarean section or cesarean section with tubal sterilization
-Pfannenstiel incision
-spinal block
-BMI < 35 kg/mm2

Exclusion Criteria

No history of NSAIDs,sulfa group and opioid groug allery
No liver,hematology,renal and heart disease
No currently warfarin tak
Opertive time <= 2 hours
Blood loss<= 1000 ml

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain score at rest and movement 24 hour Visual analogue scale,Pain score at rest and movement 6 and 12 hours Visual analogue scale
Secondary Outcome Measures
NameTimeMethod
PCA pethidine used 24 hours milligram,Pain score at rest and movement 6 and 12 hours visual analogue scale
© Copyright 2025. All Rights Reserved by MedPath